Atropine Sulfate Injection · #1 of 35 active shortages by FDA posting duration
FDA lists Atropine Sulfate Injection as Active Shortage (Hospira, Inc., a Pfizer Company).
Availability on file: Unavailable
Atropine Sulfate Injection: Active Shortage
Unavailable 18 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Atropine Sulfate Injection
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Dosage Form
- Injection
- Presentation
- Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4910-34)"
- Package NDC
- 0409-4910-34
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Jan 1, 2012
- Last Updated
- Mar 13, 2026
- Therapeutic Category
- Anesthesia, Neurology, Pediatric
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
Full Drug Profile
atropine
Side effects, interactions, warnings & more
Nearby, Other Atropine Shortage Records
Atropine Sulfate Injection
Accord Healthcare Inc.
Injection
Atropine Sulfate Injection
Accord Healthcare Inc.
Injection
Atropine Sulfate Injection
American Regent, Inc.
Injection
Atropine Sulfate Injection
Accord Healthcare Inc.
Injection
Atropine Sulfate Injection
American Regent, Inc.
Injection
Atropine Sulfate Injection
Accord Healthcare Inc.
Injection
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.